RootPath

General Information

Company Name

RootPath

Founded Year

2017

Location (Offices)

Framingham, United States +1

Founders / Decision Makers

Number of Employees

Industries

Biotechnology

Funding Stage

Series B

Social Media

RootPath - Company Profile

RootPath is a synthetic biology company that was founded in 2017 and is headquartered in the United States. The company's slogan emphasizes its focus on elevating the throughput of gene function interrogation through synthetic biology. RootPath aims to achieve this by enabling biology at scale. In its most recent funding round, the company raised a substantial $50.00M in a Series B investment, which took place on 07 September 2021. The investors included Sky9 Capital, CDH Investments, Matrix Partners China, and Hony Capital.

Taxonomy: synthetic biology, gene function, interrogation, T cell therapy, personalized medicine, cancer immunotherapy, precision medicine, cancer diagnosis, cancer treatment, Cambridge-based, biotechnology company, next-generation technologies, immune system modulation, cancer revolution